SCHEMBL370670

SCHEMBL370670

Cn1cc(C(=O)CC(c2cccc(C(=O)O)c2)c2ccc(Cl)cc2F)ccc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
BRD4 O60885 1/20 0.36
MDM2 Q00987 1/20 0.34
PLA2G4A P47712 3/20 0.34
CTSA P10619 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
EIF4EBP1 Q13541 1/20 0.34
MGAM O43451 3/20 0.34
GAA P10253 3/20 0.34
SI P14410 3/20 0.34
MGAM2 Q2M2H8 3/20 0.34
POLB P06746 2/20 0.34
CYP2C9 P11712 1/20 0.34
LTB4R Q15722 1/20 0.34
ADRB1 P08588 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369536 0.90 POLB (0.38) CREBBPMEN1KMT2AMDM2MGAM
SCHEMBL1390349 0.89 BAZ2B (0.36) CREBBPMEN1KMT2ABRD4
SCHEMBL369530 0.88 CREBBP (0.37) CREBBPMEN1KMT2ABRD4POLB
SCHEMBL368299 0.87 ADRA1D (0.36) CREBBPMEN1KMT2ABRD4MDM2
SCHEMBL368926 0.87 BRD4 (0.35) CREBBPMEN1KMT2ABRD4CYP2C9
SCHEMBL1390327 0.86 CREBBP (0.42) CREBBPMEN1KMT2ABRD4MDM2
SCHEMBL368821 0.86 PHGDH (0.39) GAA
SCHEMBL1390467 0.85 POLB (0.37) MEN1KMT2ABRD4MDM2MGAM
SCHEMBL371366 0.84 KMT2A (0.46) KMT2ABRD4MDM2MGAMGAA
SCHEMBL369928 0.83 CYP2C9 (0.39) KMT2AMDM2MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 CREBBP 2198/4885MRGPRX4 133/4885MEN1 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.